NM_014363.6:c.8956C>G
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_014363.6(SACS):c.8956C>G(p.His2986Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,613,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. H2986H) has been classified as Likely benign.
Frequency
Consequence
NM_014363.6 missense
Scores
Clinical Significance
Conservation
Publications
- Charlevoix-Saguenay spastic ataxiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SACS | NM_014363.6 | MANE Select | c.8956C>G | p.His2986Asp | missense | Exon 10 of 10 | NP_055178.3 | ||
| SACS | NM_001437336.1 | c.8983C>G | p.His2995Asp | missense | Exon 11 of 11 | NP_001424265.1 | |||
| SACS | NM_001278055.2 | c.8515C>G | p.His2839Asp | missense | Exon 8 of 8 | NP_001264984.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SACS | ENST00000382292.9 | TSL:5 MANE Select | c.8956C>G | p.His2986Asp | missense | Exon 10 of 10 | ENSP00000371729.3 | ||
| SACS | ENST00000455470.6 | TSL:1 | c.2432-5436C>G | intron | N/A | ENSP00000406565.2 | |||
| SACS | ENST00000682944.1 | c.8983C>G | p.His2995Asp | missense | Exon 11 of 11 | ENSP00000507173.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152102Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250636 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461638Hom.: 0 Cov.: 37 AF XY: 0.00000550 AC XY: 4AN XY: 727114 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152102Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74308 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
This sequence change replaces histidine, which is basic and polar, with aspartic acid, which is acidic and polar, at codon 2986 of the SACS protein (p.His2986Asp). This variant is present in population databases (rs751888795, gnomAD 0.003%). This missense change has been observed in individual(s) with spastic ataxia (PMID: 28454995). ClinVar contains an entry for this variant (Variation ID: 558044). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SACS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Charlevoix-Saguenay spastic ataxia Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at